Philip V. Hassard

Statistics

Publications

Citations

1.2K

H-Index

Active since

1999

Affiliations

Cedars-Sinai Medical Center(Current)

Ottawa Hospital

University of Ottawa

Université de Montréal

Philip V. Hassard is an author at Cedars-Sinai Medical Center specializing in inflammatory bowel disease therapy, inflammatory bowel disease, and pharmacotherapy.

Publications per year

1999–2007

Publications

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease

Marla C. Dubinsky, Huiying Yang, Philip V. Hassard et al. · Gastroenterology · 2002 · 485 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease

Eric A. Vasiliauskas, Lori Y. Kam, Maria T. Abreu-Martin et al. · Gastroenterology · 1999 · 286 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report

Philip V. Hassard, Scott W. Binder, Viera Nelson et al. · Gastroenterology · 2001 · 177 citations · Full text

Life Sciences, Immunology, Autoimmunity +10

An Open-Label Pilot Study Using Thioguanine as a Therapeutic Alternative in Crohn's Disease Patients Resistant to 6-Mercaptopurine Therapy

Marla C. Dubinsky, Philip V. Hassard, Ernest G. Seidman et al. · Inflammatory Bowel Diseases · 2001 · 140 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease

Philip V. Hassard, Eric A. Vasiliauskas, Lori Y. Kam et al. · Inflammatory Bowel Diseases · 2007 · 49 citations

Pharmacy, Immunology, Pharmacotherapy +16

1–5 of 7